Pulocimab is a monoclonal antibody targeting VEGFR2 (vascular endothelial growth factor receptor 2), designed for use in cancer research. This antibody binds specifically to VEGFR2, inhibiting its signaling pathways, which are critical for tumor angiogenesis and growth. Pulocimab offers a valuable tool for researchers studying the molecular mechanisms of cancer progression and exploring potential therapeutic strategies targeting angiogenesis.
Pulocimab is a monoclonal antibody targeting VEGFR2 (vascular endothelial growth factor receptor 2), designed for use in cancer research. This antibody binds specifically to VEGFR2, inhibiting its signaling pathways, which are critical for tumor angiogenesis and growth. Pulocimab offers a valuable tool for researchers studying the molecular mechanisms of cancer progression and exploring potential therapeutic strategies targeting angiogenesis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
